Form 8-K - Current report:
SEC Accession No. 0001104659-26-080316
Filing Date
2026-07-02
Accepted
2026-07-02 16:06:39
Documents
14
Period of Report
2026-07-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2618959d1_8k.htm   iXBRL 8-K 27044
2 EXHIBIT 5.1 tm2618959d1_ex5-1.htm EX-5.1 12331
6 GRAPHIC tm2618959d1_8kimg001.jpg GRAPHIC 16480
7 GRAPHIC tm2618959d1_ex5-1img01.jpg GRAPHIC 3828
  Complete submission text file 0001104659-26-080316.txt   259683

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mtva-20260702.xsd EX-101.SCH 3017
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtva-20260702_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtva-20260702_pre.xml EX-101.PRE 22360
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2618959d1_8k_htm.xml XML 3212
Mailing Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138 (857) 702-9600
MetaVia Inc. (Filer) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37809 | Film No.: 261151091
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)